Pharmacokinetic Study of Oligonucleotides in Maixuekang Capsules
Status:
RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
The objective of this clinical trial is to learn the sequence and expression level of Maixuekang oligonucleotides in the plasma of healthy volunteers.
1. Detecting the sequence and expression levels of oligonucleotides in the blood of healthy subjects before and after a single administration of Maixuekang at different time points.
2. Detecting the sequence and expression levels of oligonucleotides in the blood of healthy subjects before and after multiple administrations of Maixuekang at different time points.
Single dose group: Participants will be given Maixuekang capsules once, 1g, orally.
Multiple dose group: Participants will receive 1g of Maixuekang capsules orally for 3 days, 3 times a day.